Retirement of Pfizer executive

New York: Pfizer business development VP William Ringo is to retire.

Retirement of Pfizer executive

He will be replaced by Kristin Peck, a senior strategy executive with the company since 2004.

Mr Ringo played a key role in the recent acquisition of Wyeth, he helped create specialist HIV company ViiV Healthcare through a joint venture with GlaxoSmithKline; and he played a leadership role in securing rights to a number of novel, promising compounds.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited